Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

36.51
Delayed Data
As of Dec 09
 +0.45 / +1.25%
Today’s Change
33.60
Today|||52-Week Range
55.51
-32.48%
Year-to-Date
5 Stocks That Got Run Over By the Trump Train
Dec 09 / Zacks.com - Paid Partner Content
Trump warns Wall Street: I'm going to cut drug prices
Dec 07 / CNNMoney.com
Pharma Stock Roundup: Drug Pricing Heat Back on Sector, Endo, Mylan, AZN to Cut Jobs
Dec 09 / Zacks.com - Paid Partner Content
The Worst American Stocks of 2016
Dec 07 / MotleyFool.com - Paid Partner Content
5 Drug Stocks to Avoid as Trump Vows to Lower Drug Prices
Dec 08 / Zacks.com - Paid Partner Content
Here's Why Teva Pharmaceutical's (TEVA) Stock Is Down Today
Dec 06 / Zacks.com - Paid Partner Content
Pfizer (PFE) Fined for Price Hike of Anti-Epilepsy Drug in UK
Dec 08 / Zacks.com - Paid Partner Content
Mylan: This Is Going to Take a While
Dec 06 / TheStreet.com - Paid Partner Content
Mylan (MYL) Stock Falls on Restructuring Plans, Layoffs
Dec 08 / Zacks.com - Paid Partner Content
Mylan Aims To Trim Global Workforce
Dec 06 / TheStreet.com - Paid Partner Content
Don't Blame Trump for Biotechs' Retreat
Dec 08 / TheStreet.com - Paid Partner Content
Is Mylan Being Really Smart -- Or Really Arrogant?
Dec 04 / MotleyFool.com - Paid Partner Content
Should Biotech Investors Worry About Donald Trump?
Dec 08 / Zacks.com - Paid Partner Content
Trump win sparks seismic shift in markets
Nov 15 / CNNMoney.com
Trump Vows to Slash Drug Prices, Sends Biotech Stocks Lower
Dec 07 / Zacks.com - Paid Partner Content
Clinton defeat provides antidote to US drugmakers
Nov 10 / FT.com - Paid Partner Content